{
    "nctId": "NCT01771497",
    "briefTitle": "Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring",
    "officialTitle": "Koning Breast CT (KBCT)-Guided Neoadjuvant Treatment of Breast Cancer Monitoring Phase I Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 12,
    "primaryOutcomeMeasure": "Tumor volume change from baseline during neoadjuvant treatment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female gender\n* Age 18 years or older\n* Any ethnicity\n* Are undergoing neoadjuvant therapy for locally advanced breast cancer with either chemotherapy or hormonal therapy\n* Is able to provide informed consent.\n\nExclusion Criteria:\n\n* Pregnancy\n* Lactation\n* Women who are unable or unwilling to understand or to provide informed consent\n* Women with physical limitations that may prohibit resting prone on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pace maker.\n* Women who are unable to tolerate study constraints.\n* Women who have received radiation treatments to the thorax for malignant and nonmalignant conditions, such as (but not limited to):\n* Treatment for enlarged thymus gland as an infant\n* Irradiation for benign breast conditions, including breast inflammation after giving birth\n* Treatment for Hodgkin's disease\n* Women who have participated in a prior breast clinical trial that gave additional radiation dose, such as an additional mammogram.\n* Women who have received large numbers of diagnostic x-ray examinations for monitoring of disease such as (but not limited to):\n* Tuberculosis\n* Severe scoliosis",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}